Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
Pharmaids Pharmaceuticals Share Price
Pharmaids Pharmaceutica...
Pharmaids Pharm share price insights
Company has posted a loss of Rs 5.52 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
Stock gave a 3 year return of 118.97% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Company has spent 10.38% of its operating revenues towards interest expenses and 60.85% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Pharmaids Pharmaceuticals Ltd. share price moved down by -0.02% from its previous close of Rs 48.83. Pharmaids Pharmaceuticals Ltd. stock last traded price is 48.82
Share Price Value Today/Current/Last 48.82 Previous Day 48.83
Key Metrics
PE Ratio (x) | -19.22 | ||||||||||
EPS - TTM (₹) | -2.54 | ||||||||||
MCap (₹ Cr.) | 170.17 | ||||||||||
Sectoral MCap Rank | 117 | ||||||||||
PB Ratio (x) | 2.44 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.00 | ||||||||||
VWAP (₹) | 48.25 | ||||||||||
52W H/L (₹) |
Pharmaids Pharm Share Price Returns
1 Day | -0.02% |
1 Week | 7.3% |
1 Month | -6.51% |
3 Months | -26.14% |
1 Year | N.A. |
3 Years | 205.13% |
5 Years | N.A. |
Pharmaids Pharm News & Analysis
Pharmaids Pharm Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Pharmaids Pharm Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
PAT: Troublesome Times
Company has posted a loss of Rs 5.52 cr for the 4th consecutive quarter. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 10.38% of its operating revenues towards interest expenses and 60.85% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Quarterly | Annual Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Total Income 5.93 -0.88 -0.26 0.37 0.00 Total Income Growth (%) -773.14 241.51 -169.27 - - Total Expenses 12.02 1.33 1.03 1.58 8.60 Total Expenses Growth (%) 803.69 29.17 -34.75 -81.66 1,124.12 EBIT -6.09 -2.21 -1.29 -1.21 -8.60 EBIT Growth (%) - - - - - Profit after Tax (PAT) -5.52 -1.63 -0.50 -1.30 -6.16 PAT Growth (%) - - - - - EBIT Margin (%) -102.82 251.08 499.42 -324.02 - Net Profit Margin (%) -93.16 185.68 195.71 -349.47 - Basic EPS (₹) -2.82 -0.76 -0.24 -0.61 -4.76 All figures in Rs Cr, unless mentioned otherwise
Insights
Undertaking New Debt
Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
Annual FY 2024 FY 2023 Total Assets 91.34 24.59 Total Assets Growth (%) 271.50 121.26 Total Liabilities 20.84 - Total Liabilities Growth (%) - - Total Equity 70.50 22.46 Total Equity Growth (%) 213.88 159.01 Current Ratio (x) 1.17 8.23 Total Debt to Equity (x) 0.07 0.00 Contingent Liabilities 0.00 - All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 74.99 cr for investing activities which is an YoY increase of 1417.01%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 Net Cash flow from Operating Activities -10.62 -4.02 Net Cash used in Investing Activities -74.99 -4.94 Net Cash flow from Financing Activities 77.66 21.31 Net Cash Flow -7.95 12.35 Closing Cash & Cash Equivalent 4.80 12.75 Closing Cash & Cash Equivalent Growth (%) -62.33 3,030.27 Total Debt/ CFO (x) -0.50 0.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 Return on Equity (%) -11.05 -33.64 Return on Capital Employed (%) -17.61 -44.09 Return on Assets (%) -8.72 -30.72 Interest Coverage Ratio (x) -7.86 -2,135.71 Asset Turnover Ratio (x) 0.26 - Price to Earnings (x) -23.04 -6.19 Price to Book (x) 2.55 2.08 EV/EBITDA (x) -14.79 -3.44 EBITDA Margin (%) -81.57 0.00
Pharmaids Pharm Peer Comparison
Pharmaids Pharm Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 118.97% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 118.97% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 118.97% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 118.97% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Pharmaids Pharm Board Meeting/AGM
Pharmaids Pharm Dividends
- Others
Meeting Date Announced on Purpose Details May 28, 2024 May 21, 2024 Board Meeting Audited Results Feb 12, 2024 Feb 02, 2024 Board Meeting Quarterly Results Jan 31, 2024 Jan 08, 2024 EGM - Jan 06, 2024 Jan 03, 2024 Board Meeting Preferential issue of shares Nov 11, 2023 Nov 06, 2023 Board Meeting Quarterly Results Dividend announcements are not available.
No other corporate actions details are available.
About Pharmaids Pharm
Executives
Auditors
- MM
Mini Manikantan
Executive DirectorVMVenu Madhava Kaparthy
Executive DirectorVRVenkata Rao Sadhanala
Non Exe.Non Ind.DirectorMNMethuku Nagesh
Independent DirectorShow More - PPKG & Co.Rakesh S Jain & Associates
Industry
Key Indices Listed on
-
Address
Unit 201,, Brigade Rubix, 2nd Floor,20/14, HMT Factory Main Road,Peenya Plantation,Bengaluru, Karnataka - 560013
More Details
FAQs about Pharmaids Pharm share
- 1. What's the Pharmaids Pharm share price today?As on 18 Jul, 2024, 11:54 AM IST Pharmaids Pharm share price was down by 0.02% basis the previous closing price of Rs 48.85. Pharmaids Pharm share price was Rs 48.82. Return Performance of Pharmaids Pharm Shares:
- 1 Week: Pharmaids Pharm share price moved up by 7.30%
- 1 Month: Pharmaids Pharm share price moved down by 6.51%
- 3 Month: Pharmaids Pharm share price moved down by 26.14%
- 6 Month: Pharmaids Pharm share price moved down by 16.42%
- 2. What are the key metrics to analyse Pharmaids Pharm Share Price?Pharmaids Pharm share can be quickly analyzed on following metrics:
- Stock's PE is -19.22
- Price to Book Ratio of 2.44
- 3. What are the Pharmaids Pharm quarterly results?Total Revenue and Earning for Pharmaids Pharm for the year ending 2024-03-31 was Rs 15.99 Cr and Rs -7.97 Cr on Consolidated basis. Last Quarter 2024-03-31, Pharmaids Pharm reported an income of Rs 5.93 Cr and loss of Rs -5.52 Cr.
- 4. Which are the key peers to Pharmaids Pharm?Within Pharmaceuticals sector Pharmaids Pharm, Mangalam Drugs and Organics Ltd., Tyche Industries Ltd., Smruthi Organics Ltd., Krebs Biochemicals & Industries Ltd., Bal Pharma Ltd., Alpa Laboratories Ltd., Aarey Drugs & Pharmaceuticals Ltd., Madhuveer Com 18 Network Ltd., BDH Industries Ltd. and Bafna Pharmaceuticals Ltd. are usually compared together by investors for analysis.
- 5. Who are the key owners of Pharmaids Pharm stock?Promoter owns 9.25, shares of Pharmaids Pharm as on 31 Mar 2024
- Promoter holding have gone down from 9.25 (31 Dec 2023) to 5.64 (31 Mar 2024)
- Other investor holding has gone up from 90.75 (31 Dec 2023) to 94.36 (31 Mar 2024)
- 6. What are the returns for Pharmaids Pharm share?Return Performance of Pharmaids Pharm Shares:
- 1 Week: Pharmaids Pharm share price moved up by 7.30%
- 1 Month: Pharmaids Pharm share price moved down by 6.51%
- 3 Month: Pharmaids Pharm share price moved down by 26.14%
- 6 Month: Pharmaids Pharm share price moved down by 16.42%
- 7. What is the PE & PB ratio of Pharmaids Pharm?The PE ratio of Pharmaids Pharm stands at -19.22, while the PB ratio is 2.44.
- 8. What is Pharmaids Pharm's 52 week high / low?In last 52 weeks Pharmaids Pharm share had a high price of Rs 79.23 and low price of Rs 31.79
- 9. What is the market cap of Pharmaids Pharm?Market Capitalization of Pharmaids Pharm stock is Rs 170.17 Cr.
Trending in Markets
Pharmaids Pharm Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.